The portfolio of our preclinical Neuropharmacology group covers various validated transgenic and non-transgenic in vivo and in vitro models for neurodegeneration such as AD, PD, for orphan diseases including HD and ALS , for lipid storage disease and dyslipidemia, and for diseases like psychosis, anxiety, schizophrenia, or autism. read more
QPS Austria CEO & Leadership Team Ratings
Manfred Windisch and the QPS Austria leadership team are scored an A+ by 3 employees placing it in the Top 5% of companies sized 1,001-5,000 Employees. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.
Based on 7 ratings, the Leadership score of 90/100 combines employee feedback on their CEO (100/100), Manager (83/100), and Executive Team (100/100).
Manfred Windisch QPS Austria CEO Rating
Top 5% Compared to other companies of similar sizeA+
100 / 100
Manfred Windisch the CEO of QPS Austria received an average score of 100 from QPS Austria employees.QPS Austria Manager Rating
Top 20% Compared to other companies of similar sizeB+
83 / 100
QPS Austria Executive Team Rating
Top 5% Compared to other companies of similar sizeA+
100 / 100
×